AI assistant
Sending…
Skye Bioscience, Inc. — Director's Dealing 2024
Sep 4, 2024
34097_dirs_2024-09-04_e5dc38e2-0afe-44b5-aa3a-2cae6afd17df.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Skye Bioscience, Inc. (SKYE)
CIK: 0001516551
Period of Report: 2024-09-03
Reporting Person: Arora Puneet S. (Chief Medical Officer)
More from Skye Bioscience, Inc.
Declaration of Voting Results & Voting Rights Announcements
2026
May 29
Delisting Announcement
2026
May 15
Annual Report
2026
Apr 16
Proxy Solicitation & Information Statement
2026
Apr 16
Board/Management Information
2026
Apr 3
Delisting Announcement
2026
Mar 19
Board/Management Information
2026
Feb 20
Director's Dealing
2026
Feb 10
Director's Dealing
2026
Feb 10
Director's Dealing
2026
Feb 10